Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 5N79Z | IM / LA |
Patient received invalid dose of Arexvy RSV vaccine. They had already received 1 dose on 12/5/2024 completing requirements. They then received a 2nd dose on 5/5/2026. No adverse effects have been reported
None listed
N/A
N/A
None